Associated Papers
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.
Bogucka-Janczi K et al.
Elife, 2023
Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors.
Grädler U et al.
Bioorganic & Medicinal Chemistry Letters, 2020
L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.
Alsaran H et al.
Scientific Reports, 2017
C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
Tanguay PL et al.
The Biochemical Journal, 2010
Scaffolding by ERK3 regulates MK5 in development.
Schumacher S et al.
The Embo Journal, 2004
Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression.
Julien C et al.
The Journal of Biological Chemistry, 2003
ERK3 is a constitutively nuclear protein kinase.
Cheng M et al.
The Journal of Biological Chemistry, 1996
Select a paper to view details